4-[2-oxo-3-[3-(oxolan-2-yl)-2H-indazol-6-yl]propyl]-N-[1-(trifluoromethyl)cyclopropyl]pyridine-2-carboxamide
C24H23F3N4O3 — CID 164971821
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-[2-oxo-3-[3-(oxolan-2-yl)-2H-indazol-6-yl]propyl]-N-[1-(trifluoromethyl)cyclopropyl]pyridine-2-carboxamide
4-[2-oxo-3-[3-(oxolan-2-yl)-2H-indazol-6-yl]propyl]-N-[1-(trifluoromethyl)cyclopropyl]pyridine-2-carboxamide (PubChem CID 164971821) has the molecular formula C24H23F3N4O3 and a molecular weight of 472.47 g/mol. Its IUPAC name is 4-[2-oxo-3-[3-(oxolan-2-yl)-2H-indazol-6-yl]propyl]-N-[1-(trifluoromethyl)cyclopropyl]pyridine-2-carboxamide.
Molecular Properties
| Compound Name | 4-[2-oxo-3-[3-(oxolan-2-yl)-2H-indazol-6-yl]propyl]-N-[1-(trifluoromethyl)cyclopropyl]pyridine-2-carboxamide |
|---|---|
| PubChem CID | 164971821 |
| Molecular Formula | C24H23F3N4O3 |
| Molecular Weight | 472.47 g/mol |
| Exact Mass | 472.17 |
| IUPAC Name | 4-[2-oxo-3-[3-(oxolan-2-yl)-2H-indazol-6-yl]propyl]-N-[1-(trifluoromethyl)cyclopropyl]pyridine-2-carboxamide |
| SMILES | O=C(Cc1ccnc(C(=O)NC2(C(F)(F)F)CC2)c1)Cc1ccc2c(C3CCCO3)[nH]nc2c1 |
| InChI | InChI=1S/C24H23F3N4O3/c25-24(26,27)23(6-7-23)29-22(33)19-13-15(5-8-28-19)11-16(32)10-14-3-4-17-18(12-14)30-31-21(17)20-2-1-9-34-20/h3-5,8,12-13,20H,1-2,6-7,9-11H2,(H,29,33)(H,30,31) |
| InChIKey | DFNTVDVRUVRWER-UHFFFAOYSA-N |
| XLogP | 3.99 |
| TPSA | 96.97 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 34 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 472.47 |
| LogP ≤ 5 | 3.99 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 164971821 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.